Aclidinium bromide/formoterol explained
Type: | combo |
Component1: | Aclidinium bromide |
Class1: | Long-acting muscarinic antagonist |
Component2: | Formoterol |
Class2: | Long-acting β2 agonist |
Tradename: | Brimica Genuair, Duaklir Genuair, Duaklir Pressair |
Dailymedid: | Duaklir |
Pregnancy Au: | B3 |
Pregnancy Us: | N |
Routes Of Administration: | Inhalation |
Atc Prefix: | R03 |
Atc Suffix: | AL05 |
Legal Au: | S4 |
Legal Uk: | POM |
Legal Uk Comment: | [1] |
Legal Us: | Rx-only |
Legal Us Comment: | [2] |
Legal Eu: | Rx-only |
Legal Status: | Rx-only |
Cas Number: | 2446159-07-3 |
Kegg: | D11857 |
Aclidinium bromide/formoterol, sold under the brand names Duaklir and Brimica, is a fixed-dose combination medication for inhalation, used in the management of chronic obstructive pulmonary disease (COPD).[3] It consists of aclidinium bromide, a long-acting muscarinic antagonist, and formoterol, a long-acting β2 agonist.[4] [5]
External links
- Web site: Aclidinium bromide . U.S. National Library of Medicine . Drug Information Portal .
- Web site: Formoterol fumarate . U.S. National Library of Medicine . Drug Information Portal .
Notes and References
- Web site: Duaklir Genuair 340 micrograms /12 micrograms inhalation powder - Summary of Product Characteristics (SmPC) . (emc) . 9 September 2019 . 26 July 2020 . 26 July 2020 . https://web.archive.org/web/20200726223834/https://www.medicines.org.uk/emc/product/3562/smpc . dead .
- Web site: Duaklir Pressair- aclidinium bromide and formoterol fumarte powder, metered . DailyMed . 3 July 2020 . 28 November 2020.
- D'Urzo AD, Singh D, Donohue JF, Chapman KR, Wise RA . Aclidinium bromide/formoterol fumarate as a treatment for COPD: an update . Expert Review of Respiratory Medicine . 15 . 9 . 1093–1106 . September 2021 . 34137664 . 10.1080/17476348.2021.1920403 . 235460050 .
- Web site: Duaklir Genuair EPAR . European Medicines Agency (EMA) . 26 July 2020.
- Web site: Brimica Genuair EPAR . European Medicines Agency (EMA) . 26 July 2020.